Management of Severe Aortic Stenosis in the Young Adult Patient: Long View

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Stefano Schena, MD, PhD

Gregory Fontana, MD
Disclosure: Abbott/St. Jude Medical: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing); Edwards Life Science: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing)

Presentations

  1. Case Presentation: 44 year-old professional golfer with severe symptomatic AS
    Najiha Farooqi, MD
     
  2. Initial Surgical AVR
    Dawn Hui, MD
    Disclosure: Astellas Pharmaceuticals: Department received funds for research support; I personally did not receive any financial benefit (Terminated)
     
  3. Recent clinical outcomes of surgical redo aortic valve replacement in patients with prosthetic valve failure
    Jae Woong Choi
     
  4. TAVR as First Choice in Young Adults: Is There a Role?
    Kendra J. Grubb, MD, MHA, FACC
    Disclosure: 4C Medical: Advisory Board (Ongoing); Abbott: Advisory Board (Ongoing); Ancora: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Life Science: Educational Grant (Ongoing), Speaker (Ongoing); HLT Medical: Advisory Board (Terminated); Medtonic: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore & Associates: Consultant (Ongoing)
     
  5. Aortic Valve Replacement in Patients with Asymptomatic Severe Aortic Stenosis and Preserved Systolic Function: Evolving Concept in Timing of Intervention
    Hoda Javadikasgari, MD
     
  6. Ross Procedure as First Strategy
    Ismail El-Hamamsy, MD, PhD
     
  7. Panel Discussion
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
02/01/2023
Activity expires: 
02/01/2026
Cost:
$0.00
Part of: 
2023 STS Annual Meeting Online: Adult Cardiac Track
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Stefano Schena, MD, PhD

Gregory Fontana, MD
Disclosure: Abbott/St. Jude Medical: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing); Edwards Life Science: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing)

Presentations

  1. Case Presentation: 44 year-old professional golfer with severe symptomatic AS
    Najiha Farooqi, MD
     
  2. Initial Surgical AVR
    Dawn Hui, MD
    Disclosure: Astellas Pharmaceuticals: Department received funds for research support; I personally did not receive any financial benefit (Terminated)
     
  3. Recent clinical outcomes of surgical redo aortic valve replacement in patients with prosthetic valve failure
    Jae Woong Choi
     
  4. TAVR as First Choice in Young Adults: Is There a Role?
    Kendra J. Grubb, MD, MHA, FACC
    Disclosure: 4C Medical: Advisory Board (Ongoing); Abbott: Advisory Board (Ongoing); Ancora: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Life Science: Educational Grant (Ongoing), Speaker (Ongoing); HLT Medical: Advisory Board (Terminated); Medtonic: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore & Associates: Consultant (Ongoing)
     
  5. Aortic Valve Replacement in Patients with Asymptomatic Severe Aortic Stenosis and Preserved Systolic Function: Evolving Concept in Timing of Intervention
    Hoda Javadikasgari, MD
     
  6. Ross Procedure as First Strategy
    Ismail El-Hamamsy, MD, PhD
     
  7. Panel Discussion